Society of Interventional Radiology Names Robert J Lewandowski, MD, FSIR, President for 2024–2025

Dr. Robert J Lewandowski

Robert J. Lewandowski, MD, FSIR, an interventional radiologist and professor at Northwestern Medicine Feinberg School of Medicine, Chicago, assumed the office of president of the Society of Interventional Radiology (SIR) on March 26 during the SIR 2024 Annual Scientific Meeting in Salt Lake City.

“Throughout the last 50 years, SIR has enabled the specialty to grow in an evolving healthcare landscape, providing IRs with the education, resources, and support required for members to thrive,” said Lewandowski. “As we look forward, SIR remains committed to fostering healthcare innovations that improve patients’ lives worldwide.”

Other incoming officers of SIR’s 2024–2025 Board of Directors include President-elect Robert A. Lookstein, MD, FSIR, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York; newly appointed Secretary Saher S. Sabri, MD, FSIR, MedStar Georgetown University Hospital; and Immediate Past-president Alda L. Tam, MD, MBA, FSIR, The University of Texas MD Anderson Cancer Center, Houston.

Other appointed and elected SIR leadership positions filled this year are:

SIR Board of Directors

  • Kelvin Hong, MD, FSIR—Director, at-large
  • Nishita Kothary, MD, FSIR—Director, at-large

SIR and SIR Foundation Steering Council

Divisions

  • Sun-Ho Ahn, MD, FSIR—Education Division Councilor
  • Paula Novelli, MD, FSIR—2024–2030 Annual Meeting Program Committee

Clinical Specialty Councils

  • Joseph J. Gemmete, MD, FSIR—Neurointerventional Radiology Council Vice Chair
  • Gulraiz Chaudry, MD, FSIR—Pediatric IR Vice Chair
  • Andrew Gunn, MD, FSIR—Renal and GU Council Vice Chair

SIR Foundation also appointed the following members to its Board of Directors:

  • Clifford R. Weiss, MD, FSIR—Vice Chair
  • Shellie C. Josephs, MD, FSIR—Secretary
  • Nadine Abi-Jaoudeh, MD, FSIR—Clinical Trials and Registries Division Chair
  • Amy C. Taylor, MD—Development Division Chair
  • Dania Daye, MD, PhD—Research Education and Outreach Division Chair

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.